<DOC>
	<DOCNO>NCT02763423</DOCNO>
	<brief_summary>This phase II trial individual diagnose type 1 diabetes within previous 12 month suffer diabetic ketoacidosis onset disease . The purpose study determine whether allogeneic umbilical cord mesenchymal stem cell transplantation effective treatment patient severe type 1 diabetes .</brief_summary>
	<brief_title>Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation Type 1 Diabetes With Diabetic Ketoacidosis</brief_title>
	<detailed_description>To assess clinical efficacy allogeneic umbilical cord mesenchymal stem cell transplantation treatment patient severe type 1 diabetes , define history diabetic ketoacidosis diagnosis . All patient intravenously administrate single-dose double-dose umbilical cord mesenchymal stem cell follow 36 month . Clinical laboratory manifestation compare transplantation .</detailed_description>
	<mesh_term>Ketosis</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Diabetic Ketoacidosis</mesh_term>
	<criteria>Type 1 diabetes Duration disease le 12 month diagnosis With history diabetic ketoacidosis Pregnancy Severe psychiatric disorder Severe organic impairment ( renal , hepatic , cardiac , pulmonary ) Active infectious disease Previous present neoplastic disease</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>umbilical cord stem cell</keyword>
	<keyword>diabetic ketoacidosis</keyword>
</DOC>